Schechter Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Schechter Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$260K	Sell	19,710 -8,537	-30%	-$118K	0.02%	506
2024 Q4	$446K	Sell	28,247 -983	-3%	-$14.8K	0.03%	412
2024 Q3	$464K	Buy	29,230 +1,055	+4%	+$17K	0.03%	415
2024 Q2	$429K	Buy	28,175 +650	+2%	+$9.32K	0.03%	407
2024 Q1	$404K	Sell	27,525 -250	-0.9%	-$3.65K	0.03%	431
2023 Q4	$387K	Buy	27,775 +3,930	+16%	+$52.5K	0.03%	400
2023 Q3	$319K	Buy	23,845 +1,520	+7%	+$20.6K	0.03%	432
2023 Q2	$282K	Buy	22,325 +4,620	+26%	+$53.9K	0.03%	498
2023 Q1	$202K	Sell	17,705 -3,505	-17%	-$37.8K	0.02%	620
2022 Q4	$220K	Buy	+21,210	New	+$229K	0.02%	722

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schechter Investment Advisors's RDY Position: Q1 2025 in Review

Schechter Investment Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 30% in Q1 2025, selling an estimated $118K and leaving 19,710 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #506.

Schechter Investment Advisors first reported a position in RDY in Q4 2022 and has held it in 10 quarters since. The position peaked at $464K in Q3 2024. 243 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

Schechter Investment Advisors held 19,710 shares of Dr. Reddy's Laboratories worth $260K as of Q1 2025.
Schechter Investment Advisors sold 8,537 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $118K.
Dr. Reddy's Laboratories made up 0.02% of Schechter Investment Advisors's portfolio in Q1 2025, its #506 holding.
Schechter Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 10 quarters since.
Schechter Investment Advisors's Dr. Reddy's Laboratories position peaked at $464K in Q3 2024.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.